Cita APA (7a ed.)

VA, G., AK, N., S, L., & LH, B. (2013). Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma. Dove Medical Press.

Cita Chicago Style (17a ed.)

VA, Gupta, Nooka AK, Lonial S, y Boise LH. Clinical Potential of Carfilzomib in the Treatment of Relapsed and Refractory Multiple Myeloma. Dove Medical Press, 2013.

Cita MLA (8a ed.)

VA, Gupta, et al. Clinical Potential of Carfilzomib in the Treatment of Relapsed and Refractory Multiple Myeloma. Dove Medical Press, 2013.

Precaución: Estas citas no son 100% exactas.